Ekocorp Plc
NGSE:EKOCORP 株式レポート
Ekocorp マネジメント 主要情報 CEO給与比率 n/a CEO在任期間 no data CEOの所有権 n/a 経営陣の平均在職期間 データなし 取締役会の平均在任期間 データなし
経営陣の近況
No independent directors Nov 16
No independent directors Apr 27
すべての更新を表示
No independent directors Nov 16
No independent directors Apr 27
Third quarter 2021 earnings released: ₦0.15 loss per share (vs ₦0.17 loss in 3Q 2020) Nov 07
Second quarter 2021 earnings released: ₦0.13 loss per share (vs ₦0.14 loss in 2Q 2020) Aug 03
First quarter 2021 earnings released: ₦0.14 loss per share (vs ₦0.15 loss in 1Q 2020) May 05
Full year 2020 earnings released: ₦0.52 loss per share (vs ₦0.59 loss in FY 2019) Feb 01
Third quarter 2020 earnings released: ₦0.17 loss per share Nov 20
New 90-day high: ₦6.05 Oct 22
New 90-day high: ₦6.10 Oct 05
New 90-day low - ₦5.40 Aug 06
New 90-day low - ₦5.40 Jul 16
CEO（最高経営責任者 Dr. A. Adegbite Ogunmokun serves as Chief Medical Officer and Acting Chief Executive Officer at EkoCorp Plc. Dr. Ogunmokun also serves as Chief Consultant Obsterician/Gynaecologist and also Head of the Eko ... Show more
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}